ON-DEMAND WEBINAR Mapping Insertion Sites and Sequencing Transgenes with TLA
Transgenic mice are indispensable for modeling disease in biomedical research. But the site of transgene integration can have profound effects on expression – and the interpretation of critical phenotypic data.
How can you know if your transgenic animal model project is on the right track?
Mapping Insertion Sites and Sequencing Transgenes with TLA
Targeted Locus Amplification (TLA) is a NGS-based method that allows robust and precise identification of the transgene insertion site and the complete sequencing of integrated transgene sequences.
Join this exclusive webinar from Taconic Biosciences and Cergentis to learn how TLA supports more effective design and generation of transgenic animal models for preclinical research. In this webinar, expect to learn:
How does TLA work?
How does TLA support transgene and integration site sequencing?
How can TLA be used for mapping insertion sites in mission-critical transgenic lines?
Max van Min received a degree in Biotechnology from Wageningen University & Research Centre. He has previously worked in commercial management positions at DSM and Keygene. Max is co-inventor of the Targeted Locus Amplification (TLA) Technology and co-founder and CEO of Cergentis.
Dr. Gretchen Kusek is the Associate Director of Scientific Services at Taconic Biosciences. She earned her PhD from the State University of New York at Albany, Department of Biomedical Sciences, with a concentration in Molecular Genetics. Dr. Kusek has extensive experience utilizing rodent models, specializing in genetics, genomics and mammalian neurodevelopment.